TARGETING ANTIOXIDANT ENZYMES FOR THE TREATMENT OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

被引:0
|
作者
Fidyt, K. [1 ]
Szczygiel, K. [1 ]
Pastorczak, A. [2 ]
Graczyk-Jarzynka, A. [1 ]
Patkowska, E. [3 ]
Lech-Maranda, E. [3 ]
Golab, J. [1 ]
Firczuk, M. [1 ]
机构
[1] Med Univ Warsaw, Dept Immunol, Warsaw, Poland
[2] Med Univ Lodz, Dept Pediat Oncol Hematol & Diabetol, Lodz, Poland
[3] Inst Hematol & Transfus Med, Dept Hematol, Warsaw, Poland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
E827
引用
收藏
页码:340 / 341
页数:2
相关论文
共 50 条
  • [1] Tisagenlecleucel for the treatment of B-cell acute lymphoblastic leukemia
    Leahy, Allison Barz
    Elgarten, Caitlin W.
    Grupp, Stephan A.
    Maude, Shannon L.
    Teachey, David T.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (10) : 959 - 971
  • [2] Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemia
    Kotecha, Rishi S.
    Trinder, Sarah M.
    Hughes, Anastasia M.
    Mullin, Benjamin H.
    Rashid, Sarah
    Yuan, Jinbo
    Xu, Jiake
    Duncan, Owen
    Skut, Patrycja
    Chua, Grace-Alyssa
    Singh, Sajla
    Oommen, Joyce
    Lock, Richard B.
    Kees, Ursula R.
    Malinge, Sebastien
    Kuek, Vincent
    Cheung, Laurence C.
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [3] Targeted combination treatment for B-cell acute lymphoblastic leukemia
    Kane, Shriya
    Ding, Yali
    Gowda, Chandrika
    Payne, Jonathon Lee
    Iyer, Soumya
    Dhanyamraju, Pavan K.
    Song, Chunhua
    Desai, Dhimant
    Sharma, Arati
    Payne, Kimberly J.
    Dovat, Sinisa
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Inotuzumab ozogamicin in the treatment of B-cell acute lymphoblastic leukemia
    Thomas, Xavier
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (06) : 871 - 878
  • [5] LYMPHOBLAST PURINE PATHWAY ENZYMES IN B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
    REAMAN, GH
    BLATT, J
    POPLACK, DG
    BLOOD, 1981, 58 (02) : 330 - 332
  • [6] Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia
    S Takao
    W Chien
    V Madan
    D-C Lin
    L-W Ding
    Q-Y Sun
    A Mayakonda
    M Sudo
    L Xu
    Y Chen
    Y-Y Jiang
    S Gery
    M Lill
    E Park
    W Senapedis
    E Baloglu
    M Müschen
    H P Koeffler
    Leukemia, 2018, 32 : 616 - 625
  • [7] Targeting the spliceosome in high-risk B-cell acute lymphoblastic leukemia
    Murakami, Yuki
    Konishi, Hiroaki
    Tepper, Clifford
    McPherson, John
    Satake, Noriko
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia
    Takao, S.
    Chien, W.
    Madan, V.
    Lin, D-C
    Ding, L-W
    Sun, Q-Y
    Mayakonda, A.
    Sudo, M.
    Xu, L.
    Chen, Y.
    Jiang, Y-Y
    Gery, S.
    Lill, M.
    Park, E.
    Senapedis, W.
    Baloglu, E.
    Muschen, M.
    Koeffler, H. P.
    LEUKEMIA, 2018, 32 (03) : 616 - 625
  • [9] Intraocular B-cell Acute Lymphoblastic Leukemia
    Francis, Jasmine H.
    Orlin, Anton
    Stein, Eytan M.
    OPHTHALMOLOGY RETINA, 2018, 2 (08): : 826 - 826
  • [10] Targeting Bone Marrow Microenvironment for Treatment of High-Risk B-Cell Acute Lymphoblastic Leukemia
    Cheung, Laurence C.
    Trinder, Sarah
    Hughes, Anastasia
    Mullin, Benjamin
    Rashid, Sarah
    Yuan, Jinbo
    Xu, Jiake
    Duncan, Owen
    Lock, Richard B.
    Malinge, Sebastien
    Kuek, Vincent
    Kotecha, Rishi Sury
    BLOOD, 2023, 142